FDA Inspection 1132054 — Mylan Pharmaceuticals Inc.
The FDA completed an inspection of Mylan Pharmaceuticals Inc. on September 22, 2020 in San Carlos, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 22, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- San Carlos, CA (United States)